Sangamo Biosciences (SGMO) receives license fees and royalties from Dow Agro for licensing Sangamo's technology. Dow has named the product Exazct Precision Technology.
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), Arcadia Biosciences, Inc. and Bioceres, S.A. announced today an agreement to develop and commercialize innovative traits in soybeans. The collaboration leverages Dow AgroSciences’ technology, regulatory expertise, and commercial seed capabilities with a leading soybean abiotic stress platform and unique grower relationships in South America represented by Verdeca LLC, a joint venture between Arcadia and Bioceres.
Under the collaboration, the companies will develop new soybean traits using Dow AgroSciences’ EXZACT™ Precision Technology platform to generate soybean trait stacks. These stacks will combine Verdeca’s agronomic performance and product quality traits with Dow AgroSciences’ herbicide-tolerant and insect-resistant traits. The EXZACT Precision Technology platform will facilitate the development of multiple trait stacks with greater degrees of precision and speed-to-market. This collaboration is expected to result in products that provide soybean growers around the world with unique and powerful options to achieve greater yields and improved on-farm economics. Dow AgroSciences has developed the EXZACT Precision Technology platform under an exclusive license and collaboration agreement in plants with Sangamo BioSciences, Inc
No comments:
Post a Comment